vs
FIRST HAWAIIAN, INC.（FHB）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
FIRST HAWAIIAN, INC.的季度营收约是REPLIGEN CORP的1.1倍（$220.3M vs $197.9M），FIRST HAWAIIAN, INC.净利率更高（30.8% vs 6.7%，领先24.0%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 3.8%）
第一夏威夷公司是总部位于夏威夷檀香山的银行控股企业，核心子公司第一夏威夷银行成立于1858年，是夏威夷历史最悠久、规模最大的金融机构，总部设在檀香山第一夏威夷中心。该行在夏威夷设有57家分支机构，关岛有3家，塞班岛有1家，为个人及商业客户提供存款、贷款、财富管理、保险、私人银行等多元金融服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
FHB vs RGEN — 直观对比
营收规模更大
FHB
是对方的1.1倍
$197.9M
净利率更高
FHB
高出24.0%
6.7%
两年增速更快
RGEN
近两年复合增速
3.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $220.3M | $197.9M |
| 净利润 | $67.8M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 30.8% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | 14.4% | 143.9% |
| 每股收益（稀释后） | $0.55 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHBRGEN
| Q1 26 | $220.3M | — | ||
| Q4 25 | $225.9M | $197.9M | ||
| Q3 25 | $226.4M | $188.8M | ||
| Q2 25 | $217.5M | $182.4M | ||
| Q1 25 | $211.0M | $169.2M | ||
| Q4 24 | $188.1M | $174.1M | ||
| Q3 24 | $210.0M | $154.9M | ||
| Q2 24 | $204.6M | $154.1M |
净利润FHBRGEN
| Q1 26 | $67.8M | — | ||
| Q4 25 | $69.9M | $13.3M | ||
| Q3 25 | $73.8M | $14.9M | ||
| Q2 25 | $73.2M | $14.9M | ||
| Q1 25 | $59.2M | $5.8M | ||
| Q4 24 | $52.5M | $-30.3M | ||
| Q3 24 | $61.5M | $-654.0K | ||
| Q2 24 | $61.9M | $3.3M |
毛利率FHBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率FHBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 41.2% | 9.0% | ||
| Q3 25 | 42.5% | 8.9% | ||
| Q2 25 | 40.5% | 7.6% | ||
| Q1 25 | 36.5% | 3.9% | ||
| Q4 24 | 34.4% | -17.7% | ||
| Q3 24 | 36.4% | -5.1% | ||
| Q2 24 | 39.5% | 1.0% |
净利率FHBRGEN
| Q1 26 | 30.8% | — | ||
| Q4 25 | 31.0% | 6.7% | ||
| Q3 25 | 32.6% | 7.9% | ||
| Q2 25 | 33.7% | 8.2% | ||
| Q1 25 | 28.1% | 3.4% | ||
| Q4 24 | 27.9% | -17.4% | ||
| Q3 24 | 29.3% | -0.4% | ||
| Q2 24 | 30.3% | 2.2% |
每股收益（稀释后）FHBRGEN
| Q1 26 | $0.55 | — | ||
| Q4 25 | $0.56 | $0.24 | ||
| Q3 25 | $0.59 | $0.26 | ||
| Q2 25 | $0.58 | $0.26 | ||
| Q1 25 | $0.47 | $0.10 | ||
| Q4 24 | $0.41 | $-0.55 | ||
| Q3 24 | $0.48 | $-0.01 | ||
| Q2 24 | $0.48 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | $0 | $542.2M |
| 股东权益账面价值 | $2.8B | $2.1B |
| 总资产 | $24.3B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.00× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资FHBRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M |
总债务FHBRGEN
| Q1 26 | $0 | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益FHBRGEN
| Q1 26 | $2.8B | — | ||
| Q4 25 | $2.8B | $2.1B | ||
| Q3 25 | $2.7B | $2.1B | ||
| Q2 25 | $2.7B | $2.1B | ||
| Q1 25 | $2.6B | $2.0B | ||
| Q4 24 | $2.6B | $2.0B | ||
| Q3 24 | $2.6B | $2.0B | ||
| Q2 24 | $2.6B | $2.0B |
总资产FHBRGEN
| Q1 26 | $24.3B | — | ||
| Q4 25 | $24.0B | $2.9B | ||
| Q3 25 | $24.1B | $2.9B | ||
| Q2 25 | $23.8B | $2.9B | ||
| Q1 25 | $23.7B | $2.9B | ||
| Q4 24 | $23.8B | $2.8B | ||
| Q3 24 | $23.8B | $2.8B | ||
| Q2 24 | $24.0B | $2.9B |
负债/权益比FHBRGEN
| Q1 26 | 0.00× | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流FHBRGEN
| Q1 26 | — | — | ||
| Q4 25 | $335.1M | $25.7M | ||
| Q3 25 | $57.1M | $48.1M | ||
| Q2 25 | $136.4M | $28.6M | ||
| Q1 25 | $36.7M | $15.0M | ||
| Q4 24 | $317.5M | $39.2M | ||
| Q3 24 | $58.9M | $49.3M | ||
| Q2 24 | $78.2M | $42.2M |
自由现金流FHBRGEN
| Q1 26 | — | — | ||
| Q4 25 | $303.3M | $17.6M | ||
| Q3 25 | $49.5M | $43.4M | ||
| Q2 25 | $125.2M | $21.5M | ||
| Q1 25 | $28.6M | $11.4M | ||
| Q4 24 | $288.7M | $33.6M | ||
| Q3 24 | $52.3M | $42.3M | ||
| Q2 24 | $72.2M | $37.4M |
自由现金流率FHBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 134.3% | 8.9% | ||
| Q3 25 | 21.9% | 23.0% | ||
| Q2 25 | 57.5% | 11.8% | ||
| Q1 25 | 13.6% | 6.8% | ||
| Q4 24 | 153.5% | 19.3% | ||
| Q3 24 | 24.9% | 27.3% | ||
| Q2 24 | 35.3% | 24.3% |
资本支出强度FHBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 14.1% | 4.1% | ||
| Q3 25 | 3.3% | 2.5% | ||
| Q2 25 | 5.2% | 3.9% | ||
| Q1 25 | 3.8% | 2.1% | ||
| Q4 24 | 15.3% | 3.2% | ||
| Q3 24 | 3.1% | 4.5% | ||
| Q2 24 | 2.9% | 3.1% |
现金转化率FHBRGEN
| Q1 26 | — | — | ||
| Q4 25 | 4.79× | 1.93× | ||
| Q3 25 | 0.77× | 3.23× | ||
| Q2 25 | 1.86× | 1.92× | ||
| Q1 25 | 0.62× | 2.57× | ||
| Q4 24 | 6.05× | — | ||
| Q3 24 | 0.96× | — | ||
| Q2 24 | 1.26× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FHB
| Net Interest Income | $167.5M | 76% |
| Noninterest Income | $52.8M | 24% |
RGEN
暂无分部数据
